Institutional Ownership Arcutis Biotherapeutics, Inc. (ARQT)
This table provides information about the institutional ownership of Arcutis Biotherapeutics, Inc. (ARQT). We have compiled data on the 218 institutions that hold shares in the stock, with a total of 129 Million shares, which have been reported (via 13F filing form) to have a value of $1.73 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Jennison Associates LLC
|
Jan 24, 2025 Q4 2024 |
12,339,792
shares
|
$161 Million
0.11% of portfolio
|
Q4 2024
Added 5.8%
|
|
|
Suvretta Capital Management, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
11,399,138
shares
|
$148 Million
6.61% of portfolio
|
Q4 2024
Added 6.32%
|
|
|
Rubric Capital Management LP
New York, NY |
Feb 14, 2025 Q4 2024 |
10,966,672
shares
|
$143 Million
2.52% of portfolio
|
Q3 2024
Added 11.71%
|
|
|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
Feb 14, 2025 Q4 2024 |
8,785,284
shares
|
$114 Million
7.34% of portfolio
|
Q1 2024
Added 0.24%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
8,622,618
shares
|
$112 Million
0.0% of portfolio
|
Q2 2024
Added 29.49%
|
|
|
Polar Capital Holdings PLC
London, X0 |
Feb 14, 2025 Q4 2024 |
7,377,381
shares
|
$96.1 Million
0.63% of portfolio
|
Q4 2024
Added 7.16%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Feb 11, 2025 Q4 2024 |
6,440,715
shares
|
$83.9 Million
0.0% of portfolio
|
Q4 2024
Reduced 7.5%
|
|
|
State Street Corp
Boston, MA |
Feb 14, 2025 Q4 2024 |
4,950,725
shares
|
$64.5 Million
0.0% of portfolio
|
Q4 2024
Reduced 12.25%
|
|
|
Morgan Stanley
New York, NY |
Feb 14, 2025 Q4 2024 |
4,243,911
shares
|
$55.3 Million
0.0% of portfolio
|
Q4 2024
Added 12.24%
|
|
|
Gilder Gagnon Howe & CO LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
3,902,991
shares
|
$50.8 Million
0.63% of portfolio
|
Q4 2024
Added 9.82%
|
|
|
Franklin Resources Inc
San Mateo, CA |
Feb 12, 2025 Q4 2024 |
3,309,319
shares
|
$43.1 Million
0.01% of portfolio
|
Q4 2024
Reduced 22.14%
|
|
|
Ubs Group Ag
|
Feb 14, 2025 Q4 2024 |
2,789,530
shares
|
$36.3 Million
0.01% of portfolio
|
Q4 2024
Added 1166.85%
|
|
|
D. E. Shaw & Co., Inc.
New York, NY |
Feb 14, 2025 Q4 2024 |
2,513,577
shares
|
$32.7 Million
0.03% of portfolio
|
Q4 2024
Added 44.04%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Feb 12, 2025 Q4 2024 |
2,472,730
shares
|
$32.2 Million
0.0% of portfolio
|
Q4 2024
Added 0.1%
|
|
|
Ensign Peak Advisors, Inc
Salt Lake City, UT |
Feb 13, 2025 Q4 2024 |
2,374,140
shares
|
$30.9 Million
0.06% of portfolio
|
Q4 2024
Reduced 1.77%
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Feb 14, 2025 Q4 2024 |
2,310,163
shares
|
$30.1 Million
0.02% of portfolio
|
Q4 2024
Added 101.33%
|
|
|
Pivotal Bio Venture Partners Investment Advisor LLC
San Francisco, CA |
Feb 13, 2025 Q4 2024 |
2,120,508
shares
|
$27.6 Million
27.17% of portfolio
|
Q3 2024
Added 3.89%
|
|
|
Cormorant Asset Management, LP
Boston, MA |
Feb 14, 2025 Q4 2024 |
1,825,000
shares
|
$23.8 Million
2.01% of portfolio
|
Q4 2024
Reduced 21.51%
|
|
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
Feb 14, 2025 Q4 2024 |
1,753,522
shares
|
$22.8 Million
0.06% of portfolio
|
Q4 2024
Added 617.52%
|
|
|
American Century Companies Inc
Kansas City, MO |
Feb 11, 2025 Q4 2024 |
1,631,226
shares
|
$21.2 Million
0.01% of portfolio
|
Q4 2024
Added 11.4%
|
|
|
Gw&K Investment Management, LLC
Boston, MA |
Feb 05, 2025 Q4 2024 |
1,544,084
shares
|
$20.1 Million
0.18% of portfolio
|
Q4 2024
Reduced 3.11%
|
|
|
Pictet Asset Management Sa
Geneva 73, V8 |
Aug 10, 2023 Q2 2023 |
1,327,029
shares
|
$17.3 Million
0.02% of portfolio
|
Q2 2023
Reduced 19.87%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Feb 11, 2025 Q4 2024 |
1,306,167
shares
|
$17 Million
0.0% of portfolio
|
Q4 2024
Reduced 17.85%
|
|
|
Cercano Management LLC
Bellevue, WA |
Feb 14, 2025 Q4 2024 |
1,255,365
shares
|
$16.3 Million
0.46% of portfolio
|
Q4 2024
New holding
|
|
|
Jpmorgan Chase & CO
New York, NY |
Feb 12, 2025 Q4 2024 |
1,141,505
shares
|
$14.9 Million
0.0% of portfolio
|
Q4 2024
Reduced 11.98%
|